2-Adamantan-1-yl-N-[3-(4-{3-[2-(2,6-dioxo-piperidin-3-yl)-1,3-dioxo-2,3-dihydro-1H-isoindol-4-ylamino]-propoxy}-butoxy)-propyl]-acetamide

ID: ALA4520562

PubChem CID: 155542113

Max Phase: Preclinical

Molecular Formula: C35H48N4O7

Molecular Weight: 636.79

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(CC12CC3CC(CC(C3)C1)C2)NCCCOCCCCOCCCNc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O

Standard InChI:  InChI=1S/C35H48N4O7/c40-29-9-8-28(32(42)38-29)39-33(43)26-6-3-7-27(31(26)34(39)44)36-10-4-14-45-12-1-2-13-46-15-5-11-37-30(41)22-35-19-23-16-24(20-35)18-25(17-23)21-35/h3,6-7,23-25,28,36H,1-2,4-5,8-22H2,(H,37,41)(H,38,40,42)

Standard InChI Key:  MSLJXDFBVSZRMC-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 46 51  0  0  0  0  0  0  0  0999 V2000
   33.2529  -11.5244    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   33.2597  -12.3457    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.5487  -12.7556    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.5552  -13.5761    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.2709  -13.9837    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.9717  -12.7416    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.9846  -13.5583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.7655  -13.7972    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.2328  -13.1321    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   34.7447  -12.4783    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.9848  -11.6930    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   35.0303  -14.5744    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   36.0540  -13.1192    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.4726  -13.8209    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.2903  -13.8100    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.6915  -13.0976    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.2729  -12.3905    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   36.4490  -12.3999    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.0240  -11.6953    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   38.5127  -13.0877    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   19.7863  -12.2215    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.4214  -11.5402    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.5790  -11.9944    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.1261  -11.8003    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.3328  -12.2985    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.8709  -11.6166    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.5763  -11.1500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.1317  -10.4901    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.4170  -10.7482    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.8809  -10.8013    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.5793  -11.1980    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.2946  -11.6048    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.0030  -11.1862    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.3014  -12.4261    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   24.7182  -11.5930    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.4225  -11.1744    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.1377  -11.5812    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.8461  -11.1626    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   27.5613  -11.5694    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.2697  -11.1508    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.9849  -11.5576    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.6933  -11.1390    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.4085  -11.5458    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   31.1128  -11.1272    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.8280  -11.5340    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.5364  -11.1154    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  7  1  0
  6  2  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10  6  1  0
 10 11  2  0
  8 12  2  0
  9 13  1  0
 13 14  1  0
 13 18  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 16 20  2  0
 21 22  1  0
 21 23  1  0
 22 24  1  0
 23 25  1  0
 24 26  1  0
 25 26  1  0
 27 28  1  0
 23 27  1  0
 22 29  1  0
 26 30  1  0
 30 28  1  0
 28 29  1  0
 26 31  1  0
 31 32  1  0
 32 33  1  0
 32 34  2  0
 33 35  1  0
 35 36  1  0
 36 37  1  0
 37 38  1  0
 38 39  1  0
 39 40  1  0
 40 41  1  0
 41 42  1  0
 42 43  1  0
 43 44  1  0
 44 45  1  0
 45 46  1  0
 46  1  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4520562

    ---

Associated Targets(Human)

CRBN Tclin Cereblon/Ikaros (139 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 636.79Molecular Weight (Monoisotopic): 636.3523AlogP: 3.82#Rotatable Bonds: 17
Polar Surface Area: 143.14Molecular Species: NEUTRALHBA: 8HBD: 3
#RO5 Violations: 1HBA (Lipinski): 11HBD (Lipinski): 3#RO5 Violations (Lipinski): 2
CX Acidic pKa: 11.59CX Basic pKa: 2.08CX LogP: 2.30CX LogD: 2.30
Aromatic Rings: 1Heavy Atoms: 46QED Weighted: 0.17Np Likeness Score: -0.53

References

1. Steinebach C, Sosič I, Lindner S, Bricelj A, Kohl F, Ng YLD, Monschke M, Wagner KG, Krönke J, Gütschow M..  (2019)  A MedChem toolbox for cereblon-directed PROTACs.,  10  (6): [PMID:31304001] [10.1039/C9MD00185A]
2. Matyskiela, Mary E ME and 18 more authors.  2018-01-25  A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.  [PMID:28425720]

Source